MeMed raises $93M to accelerate commercialization of its hos

MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio

GlobeNewswire

January 10, 2022



MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio MeMed Contacts:Media: Will Harris, VP Marketing, MeMedpr@me-med.com IR: Kfir Emmer, CFO, MeMedkfir.emmer@me-med.comMedia Contacts:Consilium Strategic CommunicationsMeMed@consilium-comms.com

Related Keywords

Boston , Massachusetts , United States , Phoenix , Arizona , Israel , Patrick Zhang , Kfir Emmer , Us Department Of Defense , Caesara Medical Holdings , Technology Investment , Eu Commission , Drug Administration , Union Tech Ventures , Consilium Strategic Communications , Memed Key , Horizons Ventures , Shavit Capital , Social Capital , Touchwood Capital , Clai Insurance , Phoenix Insurance , Poalim Equity , Western Technology , Med Contacts , Will Harris ,